This HTML5 document contains 139 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
phttp://www.wikidata.org/prop/
wikibasehttp://wikiba.se/ontology#
n11http://dx.doi.org/10.2169/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q33874663
rdf:type
wikibase:Item
schema:description
vědecký článek научна статия scienca artikolo article scientific επιστημονικό άρθρο 2017年論文 article científic ২০১৭-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ سائنسی مضمون artikull shkencor مقالة علمية 2017年论文 научни чланак videnskabelig artikel (udgivet 2017) 2017年论文 научни чланак scientific article articolo scientifico bài báo khoa học 2017 թուականի Յունիսին հրատարակուած գիտական յօդուած wissenschaftlicher Artikel vitskapeleg artikkel 2017年論文 2017년 논문 naučni članak научная статья bilimsel makale 2017年论文 2017年論文 мақолаи илмӣ artikulong pang-agham artigo científico (publicado na 2017) מאמר מדעי مقالهٔ علمی tudományos cikk mokslinis straipsnis наукова стаття, опублікована в червні 2017 2017年论文 2017 nî lūn-bûn vitenskapelig artikkel wetenschappelijk artikel мақолаи илмӣ article scientifique (publié 2017) 2017年論文 სამეცნიერო სტატია vedecký článok artigo científico (publicado na 2017) artículo científico publicado en 2017 artículu científicu espublizáu en 2017 teaduslik artikkel 2017年论文 2017年論文 บทความทางวิทยาศาสตร์ articol științific vetenskaplig artikel tieteellinen artikkeli 2017年论文 2017年の論文 2017 թվականի հունիսին հրատարակված գիտական հոդված artykuł naukowy artigo científico
p:P577
wds:Q33874663-E721C1B4-FEB7-49DE-AFE9-03B8EB3D0E2F
wdt:P577
2017-06-01T00:00:00Z
p:P407
wds:Q33874663-258B88D5-CDBF-4881-BD1C-69C1E80A9CA4
wdt:P407
wd:Q1860
p:P2860
wds:Q33874663-11B08113-A89E-4D8F-AC73-D68261E80075 wds:Q33874663-18B4D6FA-ECC2-463F-805E-00CCE7354208 wds:Q33874663-26B71584-C3F3-43A9-B385-9330305EFF2B wds:Q33874663-40222650-64EC-4CBB-A4B2-D7B0ED14DFC4 wds:Q33874663-6C649C6A-3FD9-411E-BE1D-4D25D63C4991 wds:Q33874663-85D8F9D4-1FD2-402A-A543-49CFD5433B2E wds:Q33874663-90A9CD12-4D6C-46A8-8126-48488841886D wds:Q33874663-93F25F08-6135-4B16-B569-757113A09694 wds:Q33874663-9BCA95A3-AA83-48CF-A6F2-2645D0C859D3 wds:Q33874663-9BD2F886-30C1-43A2-B7BC-000603B9205E wds:Q33874663-9EE31BE0-D318-4AA1-8492-DF56CB3D0B70 wds:Q33874663-A48B5AD0-6BF4-44C8-8AD0-347A5AAA3957 wds:Q33874663-A71C0C41-3400-494B-95C2-9591113880BA wds:Q33874663-AD4D5429-D231-4296-9DCF-9017292A1874 wds:Q33874663-B54FB493-2C1C-49D0-B660-FA302B23B678 wds:Q33874663-C7E5CA7C-631F-42AF-8854-B7A6B3AAC689 wds:Q33874663-D225BA99-A5DC-4E68-8A67-C4CF8C4E0E1D wds:Q33874663-F727E6E0-FC07-4400-8272-AED3985DF5F2
wdt:P2860
wd:Q35023205 wd:Q30611122 wd:Q46264486 wd:Q29620534 wd:Q40941050 wd:Q74453774 wd:Q34656434 wd:Q43174291 wd:Q43252247 wd:Q33609765 wd:Q38441017 wd:Q24655666 wd:Q34585778 wd:Q40247162 wd:Q79961552 wd:Q42479292 wd:Q28379378 wd:Q36851830
p:P2093
wds:Q33874663-3AD9C918-9A1B-4FE7-A1A4-3D4A4EEC40C4 wds:Q33874663-044D12F3-F558-47DA-ADC9-FFF5A140ABF8 wds:Q33874663-DA122A08-E893-4D9D-98CD-A60CBA54254D
wdt:P2093
Hiroko Mori Yosuke Okada Yoshiya Tanaka
rdfs:label
The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus
skos:prefLabel
The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus
schema:name
The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus
p:P1476
wds:Q33874663-5A95C4C1-A9A9-43C8-B441-F978294F67DB
wdt:P1476
The Effects of Pioglitazone on Bone Formation and Resorption Markers in Type 2 Diabetes Mellitus
p:P304
wds:Q33874663-F75AA61C-474F-42A6-8D75-341536FC7A15
wdt:P304
1301-1306
p:P31
wds:Q33874663-69BFC63A-9917-49C4-8C76-7F340406AD6F
wdt:P31
wd:Q13442814
p:P921
wds:Q33874663-3B85C5B6-B9C2-40A7-81BE-2D02065BE3CC
wdt:P921
wd:Q3025883
p:P698
wds:Q33874663-F3670937-DB66-4A2B-9F41-B07B77E68D42
wdtn:P698
n12:28566590
wdt:P698
28566590
p:P1433
wds:Q33874663-00793372-7950-413A-97E8-587C65285551
wdt:P1433
wd:Q6047666
p:P433
wds:Q33874663-ED746A50-2D39-46E7-9F04-848FF698B8C0
p:P478
wds:Q33874663-3A319F12-6D59-4696-BC17-6275EA7507E6
wdt:P433
11
wdt:P478
56
p:P356
wds:Q33874663-CDB5B193-9E02-4B64-A556-948FC2E1E723
wdtn:P356
n11:INTERNALMEDICINE.56.8096
wdt:P356
10.2169/INTERNALMEDICINE.56.8096
p:P932
wds:Q33874663-0DA9D037-BE55-43EB-BC24-0AFC5869CBD3
wdt:P932
5498191